Perbedaan Star Pacific Tbk dan Organon Pharma Indonesia Tbk.: Star Pacific Tbk diperdagangkan di Rp236 (kapitalisasi pasar 276,22 M, volume 24 jam 309,9 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Star Pacific Tbk jauh lebih besar — sekitar 2,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| LPLI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 276,22 M | 104,4 M |
Volume | 309,9 rb | — |
Lot | 3,1 rb | — |
Perputaran | 73,14 jt | — |
Harga Rata-rata | 236 | — |
Nilai Transaksi | 73,14 jt | — |
Harga Ekuilibrium Indikatif | 236 | — |
Volume Ekuilibrium Indikatif | 8 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Star Pacific Tbk (the Company), was established under the name of PT Asuransi Lippo Jiwa Sakti based on Deed No. 301 dated May 28, 1983 of Misahardi Wilamarta, S.H., a notary in Jakarta, which was amended by Deed No. 130 dated August 10, 1983 by the same notary, concerning the change of the Company's name to PT Asuransi Lippo Life. Furthermore, the Company's name was again changed to Lippo E-Net Tbk based on Deed No. 87 dated June 23, 2000 of Misahardi Wilamarta, S.H., a notary in Jakarta.
Selengkapnya di halaman LPLI →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →